ClinicalTrials.Veeva
Menu

Find clinical trials for Colon Cancer in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Colonic Cancer
Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Lung Cancer
Pancreatic Cancer

Colon Cancer trials near Nashville, TN, USA:

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

doses of selected chemotherapies will be safe and tolerable for cancer patients with advanced solid tumors. The highest tolerated d...

Active, not recruiting
Breast Cancer
Colon Neoplasms
Drug: Erlotinib
Drug: Temsirolimus

Phase 1

AstraZeneca
AstraZeneca

Nashville, Tennessee, United States and 3 other locations

and irinotecan) in participants with metastatic colorectal cancer (mCRC). The main goals of this study are to:* Evaluate the efficacy of the...

Enrolling
Colorectal Cancer (CRC)
Colon Cancer
Drug: FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin)
Drug: fruquintinib

Phase 2

SCRI Development Innovations

Nashville, Tennessee, United States and 10 other locations

This first-in-human study will evaluate safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of ....

Enrolling
Advanced Cancer
Advanced Solid Tumors
Drug: PHN-012

Phase 1

Pheon Therapeutics

Nashville, Tennessee, United States and 3 other locations

is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant solid tumors...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236
Drug: RMC-9805

Phase 1

Revolution Medicines
Revolution Medicines

Nashville, Tennessee, United States and 16 other locations

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors....

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236

Phase 1, Phase 2

Revolution Medicines
Revolution Medicines

Nashville, Tennessee, United States and 15 other locations

care (FOLFOX plus bevacizumab) alone and in combination with novel oncology therapies in first-line metastatic microsatellite-stable colorectal cancer...

Active, not recruiting
Metastatic Microsatellite-stable Colorectal Cancer
Drug: FOLFOX
Drug: Bevacizumab

Phase 1, Phase 2

MedImmune
MedImmune

Nashville, Tennessee, United States and 20 other locations

dehydrogenase 1 (IDH1) arginine 132 (R132)-mutant advanced solid tumors, including but not limited to cholangiocarcinoma, chondrosarcoma, an...

Active, not recruiting
Any Solid Tumor
Glioma
Drug: LY3410738
Drug: Gemcitabine

Phase 1

Lilly
Lilly

Nashville, Tennessee, United States and 32 other locations

RSC-101 is a Phase 1a/1b clinical trial of RSC-1255 in adult study participants with advanced solid tumor malignancies who are intolerant of...

Enrolling
Colon Cancer
Lung Cancer
Drug: RSC-1255 Dose Expansion
Drug: RSC-1255 Dose Escalation

Phase 1

Rascal Therapeutics

Nashville, Tennessee, United States and 2 other locations

This is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor ...

Active, not recruiting
Any Solid Tumor
Colon Cancer
Drug: LOXO-292

Phase 1, Phase 2

Lilly
Lilly

Nashville, Tennessee, United States and 85 other locations

this study will evaluate the pharmacokinetics, pharmacodynamics and preliminary antitumor activity of ATX-559 in patients with advanced solid tumors...

Enrolling
Endometrial Cancer
Advanced Solid Tumors
Drug: ATX-559

Phase 1

Accent Therapeutics

Nashville, Tennessee, United States and 4 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems